 |
 Video: What is a Stock Split?
|
|
|
| Gilead Sciences is a biopharmaceutical company focused on advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Co. emphasizes the discovery, development, and commercialization of medicines for unmet medical needs. Its marketed products include AmBisome, Atripla, Biktarvy, Descovy (including for PrEP), Epclusa, Genvoya, Harvoni, Sovaldi, Truvada (including for PrEP), Veklury, Vemlidy, Viread, Yescarta, and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Domvanalimab, Zimberelimab, and Seladelpar for treating primary biliary cholangitis (PBC). Co. operates in over 35 countries. According to our GILD split history records, Gilead Sciences has had 5 splits. | |
|
Gilead Sciences (GILD) has 5 splits in our GILD split history database. The first split for GILD took place on February 22, 2001. This was a 2 for 1 split, meaning for each share of GILD owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. GILD's second split took place on March 08, 2002. This was a 2 for 1 split, meaning for each share of GILD owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split. GILD's third split took place on September 07, 2004. This was a 2 for 1 split, meaning for each share of GILD owned pre-split, the shareholder now owned 2 shares. For example, a 4000 share position pre-split, became a 8000 share position following the split. GILD's 4th split took place on June 25, 2007. This was a 2 for 1 split, meaning for each share of GILD owned pre-split, the shareholder now owned 2 shares. For example, a 8000 share position pre-split, became a 16000 share position following the split. GILD's 5th split took place on January 28, 2013. This was a 2 for 1 split, meaning for each share of GILD owned pre-split, the shareholder now owned 2 shares. For example, a 16000 share position pre-split, became a 32000 share position following the split.
When a company such as Gilead Sciences splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the GILD split history from start to finish, an original position size of 1000 shares would have turned into 32000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Gilead Sciences shares, starting with a $10,000 purchase of GILD, presented on a split-history-adjusted basis factoring in the complete GILD split history.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/23/2015 |
|
| End date: |
01/21/2025 |
|
| Start price/share: |
$105.54 |
|
| End price/share: |
$92.96 |
|
| Starting shares: |
94.75 |
|
| Ending shares: |
132.68 |
|
| Dividends reinvested/share: |
$24.57 |
|
| Total return: |
23.34% |
|
| Average Annual Total Return: |
2.12% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$12,334.83 |
|
| Years: |
10.00 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/23/2015 |
|
| End date: |
01/21/2025 |
|
| Start price/share: |
$105.54 |
|
| End price/share: |
$92.96 |
|
| Dividends collected/share: |
$24.57 |
|
| Total return: |
11.36% |
|
| Average Annual Total Return: |
1.08% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11,134.36 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 02/22/2001 | 2 for 1 | | 03/08/2002 | 2 for 1 | | 09/07/2004 | 2 for 1 | | 06/25/2007 | 2 for 1 | | 01/28/2013 | 2 for 1 |
|
|
Free GILD Email Alerts:
